• Montagu Acquires Tyber Medical 

    Montagu Private Equity announced on January 14 the acquisition of Tyber Medical for an undisclosed price. With this transaction, Montagu will merge Tyber Medical with its portfolio companies Intech and Resolve Surgical Technologies to create a new platform.   Tyber Medical is an orthopedic medical device manufacturer providing rapid... Read More »
  • Takara Bio USA Holdings Acquires Curio Bioscience 

    On January 15, Takara Bio USA Holdings Inc., a wholly owned subsidiary of Takara Bio Inc., announced that it acquired Curio Bioscience.   Curio Bioscience is a biotechnology company that is advancing a new generation of high-precision tools for the life sciences industry. The company has developed spatial biology capabilities to map the... Read More »
  • 2025 Kicks off With Several Big Biopharma Deals

    With the JP Morgan 43rd Annual Healthcare Conference underway in San Francisco this week, the Biotechnology and Pharmaceutical (Biopharma) sectors are seeing a flurry of activity. Many large-scale acquisitions and licensing agreements are being announced, setting the tone for an eventful year ahead in the industry. So far this year, 14 Biopharma... Read More »
  • In Motion Physical Therapy Joins PE-Backed Ivy Rehab

    Private equity-backed Ivy Rehab announced in January 2025 that it has partnered with In Motion Physical Therapy in Downingtown, Pennsylvania. Financial terms of the deal were not disclosed.  In Motion Physical Therapy is a provider of outpatient physical therapy in Pennsylvania. The company is led by a team of therapists specializing in... Read More »
  • West Physics Consulting Acquires Mid-South Medical Physics in Arkansas

    West Physics Consulting announced on January 13 that it has entered into a strategic partnership agreement with Mid-South Medical Physics. The partnership with Mid-South includes a multi-phase acquisition of Mid-South by West Physics, allowing Mid-South’s owner and President, Mr. Paul Beck, to gradually retire as West Physics supports him... Read More »
The Transcripts: Takeaways from CVS, Teladoc, and DaVita Earnings

The Transcripts: Takeaways from CVS, Teladoc, and DaVita Earnings

In our first earnings roundup, we looked at the fourth-quarter and full-year 2022 financial performance of three major publicly traded companies in the managed care market. They achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. To read more about earnings results in the managed care market, you can read that spotlight on the LevinPro HC platform here. This week, we’re looking at companies in other healthcare verticals, including retail, dialysis and eHealth. CVS Health Corporation, Teladoc Health, Inc. and DaVita Inc are all prominent in their respective fields, and their financial performance can reveal much about the... Read More »
The Managed Care Earnings Round-Up

The Managed Care Earnings Round-Up

Some of the largest Managed Care providers in the world have announced their earnings for 2022, and the results are looking promising for the Managed Care space. Humana Inc., Centene Corporation and Cigna Corp. all achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. However, M&A within the Managed Care sector slowed in 2022, with just 43 transactions announced, a 10.4% decrease from 2021 when 48 deals were announced. This decline is the result of a shift in these company’s growth strategy as they focus on cleaning up their portfolios through divestments. Humana Inc. (NYSE:HUM) Humana reported strong operating and... Read More »
People on The Move

People on The Move

In this short segment, we want to highlight two people who have recently moved companies in the healthcare space. Andrew Sartoris, MBA Andrew Sartoris, MBA is joining Regent Surgical Health as Vice President of Strategic Initiatives. Previously the Assistant Vice President of Strategy & Innovation at HCA Healthcare, Inc., Sartoris led and advanced enterprise and business unit growth initiatives in support of HCA’s portfolio of more than 180 hospitals and 2,000 ambulatory care sites in 20 states as well as across the United Kingdom. In Sartoris’ new position at Regent Surgical Health, he will use his expertise to shape Regent’s direction. He will work closely with the leadership team... Read More »
UnitedHealth Group Posts $4.9 Billion Profit in Q4:22 Earnings

UnitedHealth Group Posts $4.9 Billion Profit in Q4:22 Earnings

UnitedHealth Group (NYSE: UNH) announced its financial results for the fourth quarter ended December 31, 2022. The company offers products through two business platforms: UnitedHealthcare, which provides healthcare coverage and benefits services; and Optum, a pharmacy benefit manager and health care provider. UnitedHealth Group recorded double-digit percentage growth in revenue year over year across UnitedHealthcare and Optum, driven primarily by both lines of businesses expanding to provide more comprehensive care to a larger base of people across the U.S. The Minnetonka, Minnesota-based company reported: A 12.3% increase in net revenue from $73.7 billion in Q4:21 to $82.8 billion in... Read More »
Home Health & Hospice 2023 Outlook: Large Transactions and Innovation Fuel Optimism

Home Health & Hospice 2023 Outlook: Large Transactions and Innovation Fuel Optimism

According to data captured from the LevinPro HC database, 2022 was a historic year for healthcare M&A, with a record-breaking 2,392 transactions announced, and we expect this number to continue to climb as companies report their final deals of the year. The Home Health & Hospice (HH&H) M&A market, however, experienced an approximately 29% decline in transactions, dropping from 155 announced in 2021 to 110 announced in 2022. The home health market was hindered by industry headwinds in 2022, including staffing shortages and Medicare rate cuts. Despite the decline in M&A during 2022, when we spoke with industry experts Al Veach and Jason Harrison of Agenda Health last... Read More »
Healthcare M&A Activity Hit Record High in 2022: A Look at the Deals and Market Trends

Healthcare M&A Activity Hit Record High in 2022: A Look at the Deals and Market Trends

Despite headwinds, the healthcare M&A market thrived in 2022. Preliminary results reveal that deal activity hit a historic high of 2,409 deals, breaking the record set in 2021 by more than 150 transactions, according to data captured in our LevinPro HC database. And there’s likely a significant cache of deals to be discovered in upcoming annual and quarterly reports. The level of activity, despite rising interest rates and borrowing costs, inflation and labor costs, highlights the strength of the tailwinds, such as aging demographics, the shift to value-based care and an abundance of private equity capital. The 2023 healthcare M&A market is looking just as active.  The announced... Read More »